Obach D - Search Results

1

Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions.

Laouénan C, Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Abdel-Hamid M, Rekacewicz C, Obach D, Fontanet A, Abel L. Laouénan C, et al. Among authors: obach d. Hum Genet. 2009 Nov;126(5):697-705. doi: 10.1007/s00439-009-0721-y. Epub 2009 Jul 23. Hum Genet. 2009. PMID: 19629529

2

Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection.

Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, Trégouët DA, Obach D, El Daly M, Thiers V, Féray C, Abdel-Hamid M, Abel L, Fontanet A. Plancoulaine S, et al. Among authors: obach d. Gut. 2008 Sep;57(9):1268-74. doi: 10.1136/gut.2007.140681. Epub 2008 May 14. Gut. 2008. PMID: 18480169

3

Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood.

Abel L, Plancoulaine S, Jouanguy E, Zhang SY, Mahfoufi N, Nicolas N, Sancho-Shimizu V, Alcaïs A, Guo Y, Cardon A, Boucherit S, Obach D, Clozel T, Lorenzo L, Amsallem D, Berquin P, Blanc T, Bost-Bru C, Chabrier S, Chabrol B, Cheuret E, Dulac O, Evrard P, Héron B, Lazaro L, Mancini J, Pedespan JM, Rivier F, Vallée L, Lebon P, Rozenberg F, Casanova JL, Tardieu M. Abel L, et al. Among authors: obach d. J Pediatr. 2010 Oct;157(4):623-9, 629.e1. doi: 10.1016/j.jpeds.2010.04.020. Epub 2010 May 31. J Pediatr. 2010. PMID: 20553844

4

How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S. Obach D, et al. Hepatology. 2015 Jul;62(1):31-9. doi: 10.1002/hep.27691. Epub 2015 Feb 27. Hepatology. 2015. PMID: 25581111

5

Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y. Obach D, et al. Clin Infect Dis. 2014 Apr;58(8):1064-71. doi: 10.1093/cid/ciu066. Epub 2014 Feb 7. Clin Infect Dis. 2014. PMID: 24510934

6

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.

Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y. Cousien A, et al. Among authors: obach d. BMC Med Res Methodol. 2014 Mar 17;14:39. doi: 10.1186/1471-2288-14-39. BMC Med Res Methodol. 2014. PMID: 24635942 Free PMC article.

7

Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.

Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y. Deuffic-Burban S, et al. Among authors: obach d. J Viral Hepat. 2016 Oct;23(10):767-79. doi: 10.1111/jvh.12546. Epub 2016 May 4. J Viral Hepat. 2016. PMID: 27144512

8

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y. Deuffic-Burban S, et al. Among authors: obach d. J Hepatol. 2014 Jul;61(1):7-14. doi: 10.1016/j.jhep.2014.03.011. Epub 2014 Mar 17. J Hepatol. 2014. PMID: 24650691

9

Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.

N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y. N'Diaye DS, et al. Among authors: obach d. BMC Infect Dis. 2014 Nov 19;14:603. doi: 10.1186/s12879-014-0603-3. BMC Infect Dis. 2014. PMID: 25407690 Free PMC article.

10

Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.

Papot E, Kalampalikis N, Doumergue M, Pilorgé F, Quatremère G, Yazdanpanah Y, Préau M; ANRS-GOTA study group. Papot E, et al. BMJ Open. 2021 Nov 26;11(11):e046212. doi: 10.1136/bmjopen-2020-046212. BMJ Open. 2021. PMID: 34836895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page